| 产品描述: | AAT-008 is a potent, selective, and orally active prostaglandin EP4 receptor antagonist with Kis of 0.97 and 6.1 nM for recombinant human EP4 and recombinant rat EP4, respectively. AAT-008 exerts tumor growth delay in mice bearing CT26WT colon tumors when combined with radiotherapy. AAT-008 can be used for the study of acute and chronic inflammatory pain and cancer
. |
| 靶点: |
EP4:0.97 nM (Ki); EP4:6.1 nM (IC50) |
| 体外研究: |
AAT-008 (1 mg/kg,口服,一次) 显著减轻大鼠中由 Carrageenan 和 Complete Freund’s adjuvant (CFA) 诱导的机械痛觉过敏[1]。 AAT-008 (3-30 mg/kg,口服,每日一至两次,最长 18 天) 单独或与放疗联合使用时,延缓 Balb/c 小鼠中携带 CT26WT 结肠肿瘤的肿瘤生长[2]。 |
| 保存条件: |
-80°C 6个月;-20°C 1个月 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.411 ml |
12.054 ml |
24.107 ml |
| 5 mM |
0.482 ml |
2.411 ml |
4.821 ml |
| 10 mM |
0.241 ml |
1.205 ml |
2.411 ml |
| 50 mM |
0.048 ml |
0.241 ml |
0.482 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |